Cargando...
Adjuvant continuous metronomic adriamycin+cyclophosphamide followed by weekly nab-paclitaxel for high-risk early stage breast cancer
PURPOSE: Many studies have sought to optimize the dosing schedule of adjuvant chemotherapy in early stage breast cancer. Here we assessed the use of continuous metronomic weekly doxorubicin plus daily oral cyclophosphamide (AC) with continuous G-CSF growth factor support for 12 weeks followed by wee...
Gardado en:
| Publicado en: | Breast J |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6538296/ https://ncbi.nlm.nih.gov/pubmed/29532546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.13013 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|